| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.003 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |